1. Home
  2. IVVD vs DLNG Comparison

IVVD vs DLNG Comparison

Compare IVVD & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • DLNG
  • Stock Information
  • Founded
  • IVVD 2020
  • DLNG 2013
  • Country
  • IVVD United States
  • DLNG Greece
  • Employees
  • IVVD N/A
  • DLNG N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • DLNG Marine Transportation
  • Sector
  • IVVD Health Care
  • DLNG Consumer Discretionary
  • Exchange
  • IVVD Nasdaq
  • DLNG Nasdaq
  • Market Cap
  • IVVD 123.8M
  • DLNG 143.7M
  • IPO Year
  • IVVD 2021
  • DLNG 2013
  • Fundamental
  • Price
  • IVVD $0.65
  • DLNG $3.73
  • Analyst Decision
  • IVVD Strong Buy
  • DLNG
  • Analyst Count
  • IVVD 3
  • DLNG 0
  • Target Price
  • IVVD $7.52
  • DLNG N/A
  • AVG Volume (30 Days)
  • IVVD 1.8M
  • DLNG 45.3K
  • Earning Date
  • IVVD 05-15-2025
  • DLNG 06-26-2025
  • Dividend Yield
  • IVVD N/A
  • DLNG 2.64%
  • EPS Growth
  • IVVD N/A
  • DLNG 59.08
  • EPS
  • IVVD N/A
  • DLNG 1.05
  • Revenue
  • IVVD $25,384,000.00
  • DLNG $156,403,000.00
  • Revenue This Year
  • IVVD $606.63
  • DLNG N/A
  • Revenue Next Year
  • IVVD $83.30
  • DLNG $0.37
  • P/E Ratio
  • IVVD N/A
  • DLNG $3.41
  • Revenue Growth
  • IVVD N/A
  • DLNG N/A
  • 52 Week Low
  • IVVD $0.36
  • DLNG $3.18
  • 52 Week High
  • IVVD $2.74
  • DLNG $5.65
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 52.71
  • DLNG 57.27
  • Support Level
  • IVVD $0.52
  • DLNG $3.50
  • Resistance Level
  • IVVD $0.80
  • DLNG $3.68
  • Average True Range (ATR)
  • IVVD 0.08
  • DLNG 0.17
  • MACD
  • IVVD 0.01
  • DLNG 0.05
  • Stochastic Oscillator
  • IVVD 50.70
  • DLNG 100.00

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About DLNG Dynagas LNG Partners LP Common Units

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.

Share on Social Networks: